| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOVIE INC. | EVP Liver Cirrhosis R&D | COMMON STOCK | 47,841 | $80,851 | $1.69 | 16 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BIVI | BIOVIE INC. | 16 Feb 2023 | 1 | -$15,153 | 4 | EVP Liver Cirrhosis R&D | 22 Feb 2023, 16:47 |
| BIVI | BIOVIE INC. | 23 Nov 2022 | 1 | $0 | 4 | EVP Liver Cirrhosis R&D | 18 Jan 2023, 15:20 |
| BIVI | BIOVIE INC. | 20 Aug 2021 | 1 | $0 | 4 | EVP Liver Cirrhosis R&D | 16 Sep 2021, 12:52 |